A examine conducted by Fumagalli et al. [58] analyzed the genetic profiles of sufferers and looked at the impacts on metabolism. They specifically looked at human CHC22 clathrin, which plays a central part in intracellular site visitors of insulin-responsive glucose transporter four (GLUT4). The GLUT4 pathway may be the dominant mechanism employed